Cargando…
A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy
SIMPLE SUMMARY: Reliable predictive indicators of response to neoadjuvant chemotherapy of advanced-stage extrauterine high-grade serous carcinoma are still lacking. Moreover, changes evident in tumor samples from interval surgery are not well understood. Our retrospective study aimed to address the...
Autores principales: | Zhong, Yanping, Liu, Jinsong, Li, Xiaoran, Westin, Shannon N., Malpica, Anais, Lawson, Barrett C., Lee, Sanghoon, Fellman, Bryan M., Coleman, Robert L., Sood, Anil K., Fleming, Nicole D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916221/ https://www.ncbi.nlm.nih.gov/pubmed/33572451 http://dx.doi.org/10.3390/cancers13040704 |
Ejemplares similares
-
Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma
por: Imura, Yoshinori, et al.
Publicado: (2022) -
Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis
por: Santoro, Angela, et al.
Publicado: (2022) -
The use of Hypotension Prediction Index in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Gangakhedkar, Gauri R., et al.
Publicado: (2022) -
Extrauterine Fœtation
Publicado: (1901) -
Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma
por: Liu, Yuexin, et al.
Publicado: (2012)